Wes Wheeler to lead UPS healthcare and life sciences unit
UPS that announced Wes Wheeler, currently CEO of Marken, a wholly-owned subsidiary of UPS, has been appointed president of UPS’s global healthcare and life sciences (HCLS) unit. The move is effective immediately. In October, UPS announced plans to align all of its healthcare and life sciences operations and commercial groups within a single UPS HCLS unit.
“We are pleased to appoint Wheeler to this very important leadership role,” said David Abney, UPS chairman and CEO. “He has an impressive career and deep experience in the clinical trials, pharmaceutical, biotech and medical device industries. His expertise will complement our strategic healthcare growth and technology initiatives.”
UPS’s HCLS unit provides extensive supply chain management, cold chain, clinical trials, global transportation and other critical healthcare service operations. (mw)